tirzepatide and bowel obstruction Does Cause Obstruction? GI Risks Explained Tirzepatide-Associated Colonic Ischemia - PMC

Each pen delivers 4 doses of the 2 mg strength and will last for one month

Loss of control over eating predicts outcomes in bariatric surgery patients: a prospective, 24-month follow-up study

At Prime Surgicare, your GLP-1 treatment is medically directed from consultation through long-term maintenance after your weight goals are achieved

Providers sometimes prescribe it as part of a broader weight loss treatment plan

Spider veins are extremely common, especially as we get older

For patients experiencing weight regain or plateau, this additional weight reduction may help achieve or maintain clinically meaningful weight loss thresholds associated with improved cardiometabolic outcomes